Why A1C Isn't Enough: Insights from Dr. Ben Bikman with Dr. Ken Berry

Insulin IQ
26 Aug 202428:10

Summary

TLDRThe transcript discusses the importance of understanding insulin, particularly endogenous insulin produced by the pancreas, in managing type 2 diabetes. It challenges the misconception that beta cells fail in type 2 diabetes, emphasizing that insulin resistance and high insulin levels are often overlooked. The conversation also delves into the limitations of A1C as a diabetes indicator, the potential for diet-induced changes in red blood cell lifespan affecting A1C readings, and the role of fructose in glycation and uric acid production, highlighting the need for a more comprehensive approach to assessing metabolic health.

Takeaways

  • πŸ’‰ The speaker emphasizes the importance of understanding endogenous insulin, which is produced by the pancreas, as opposed to exogenous insulin, which is administered to diabetic patients.
  • πŸ” There's a misconception among many primary care practitioners that in type 2 diabetes, beta cells burn out and stop producing insulin as the disease progresses, which the speaker refutes.
  • πŸ“‰ The speaker argues that even when insulin production decreases in type 2 diabetes, it remains higher than the initial levels before metabolic issues arose.
  • ⚠️ The conventional focus on glucose levels in diabetes management overlooks the significance of insulin levels, which can be a more sensitive and early indicator of metabolic health.
  • 🩺 The speaker advocates for measuring fasting insulin levels early in a patient's metabolic assessment and suggests that levels below 6 micro units per milliliter indicate insulin sensitivity.
  • 🚫 There's criticism of the clinical norm that considers any fasting insulin level below 25 as normal, which the speaker believes represents severe hyperinsulinemia.
  • πŸ“š The speaker promotes the use of the oral glucose tolerance test, which provides more detailed information than the A1C test, despite the latter being more commonly used.
  • ⏳ The A1C test measures glycation, which is not solely a result of hyperglycemia but also influenced by the lifespan of red blood cells, potentially leading to false readings.
  • 🍽️ A shift towards a carnivore diet may lead to longer-lived red blood cells, which could falsely elevate A1C levels, despite improved metabolic health.
  • πŸ“ˆ The speaker suggests using fructosamine tests or monitoring uric acid levels as alternative indicators of glycation in patients with potentially skewed A1C results due to diet changes.

Q & A

  • What is the main focus of the discussion in the transcript?

    -The main focus of the discussion is the importance of understanding endogenous insulin production by the pancreas, its role in type 2 diabetes, and the misconceptions in mainstream medical practice regarding insulin and glucose metabolism.

  • Why does the speaker believe that primary care practitioners are often oblivious to the insulin produced by the pancreas?

    -The speaker believes that primary care practitioners are often oblivious to the insulin produced by the pancreas because their training and focus are primarily on managing glucose levels and administering exogenous insulin, rather than understanding the intricacies of endogenous insulin production and its impact on health.

  • What is the speaker's bold statement regarding beta cells in type 2 diabetes?

    -The speaker's bold statement is that in type 2 diabetes, beta cells never completely disappear. Instead, insulin production may decrease due to insulin resistance, but it is still higher than before the onset of metabolic issues.

  • Why does the speaker argue against the common treatment approach of pushing insulin levels higher to lower glucose in type 2 diabetics?

    -The speaker argues against this approach because it can lead to increased insulin resistance and does not improve outcomes. The more insulin that is given, the higher the risk of mortality in type 2 diabetics.

  • What does the speaker suggest as a more effective clinical marker than fasting glucose for assessing insulin resistance?

    -The speaker suggests that fasting insulin levels are a more effective clinical marker than fasting glucose for assessing insulin resistance, as it provides an insulin-centric view of metabolic health.

  • What fasting insulin levels does the speaker consider to indicate insulin sensitivity or resistance?

    -The speaker considers fasting insulin levels of six micro units per milliliter or less to be a very good sign of insulin sensitivity, while levels in the high teens to 20s indicate compromised health due to insulin resistance.

  • Why does the speaker criticize the reliance on A1C as a primary marker for metabolic health?

    -The speaker criticizes the reliance on A1C because it can be falsely elevated or decreased due to factors affecting red blood cell lifespan, not just glucose levels. This can lead to misdiagnoses and an incomplete understanding of a patient's metabolic health.

  • What alternative test does the speaker recommend for patients who follow a carnivore diet and have slightly elevated A1C levels?

    -The speaker recommends a fructosamine test for patients on a carnivore diet with slightly elevated A1C levels, as it measures glucose glycation without being influenced by red blood cell lifespan.

  • Why is there no clinical test available to measure fructose glycation, according to the speaker?

    -The speaker indicates that there is no clinical test available to measure fructose glycation, which is a significant oversight since fructose is more reactive than glucose and can lead to increased glycation and inflammation.

  • What role do ketones play in mitigating the inflammation caused by uric acid, as discussed in the transcript?

    -Ketones are discussed as having anti-inflammatory properties that can counteract the pro-inflammatory effects of uric acid, potentially explaining why some individuals on a ketogenic diet may have elevated uric acid levels but improved metabolic and inflammatory markers.

Outlines

00:00

🧬 The Misunderstanding of Insulin in Medical Practice

The speaker begins by reflecting on the evolution of their understanding of insulin from primarily knowing about exogenous insulin to focusing on endogenous insulin produced by the pancreas. They express concern that primary care practitioners are largely ignorant about the role of endogenous insulin in type 2 diabetes, commonly but incorrectly believing that beta cells fail and stop producing insulin as the disease progresses. The speaker challenges this notion, asserting that beta cells are not typically depleted in type 2 diabetes and that insulin resistance and production levels are more complex than commonly taught.

05:00

πŸ“Š Rethinking Insulin Measurement in Diabetes Management

The speaker advocates for the measurement of fasting insulin levels as a critical yet overlooked aspect of diabetes management. They argue that conventional clinical practice often prioritizes glucose levels over insulin, leading to ineffective treatment strategies. The speaker provides a range for fasting insulin levels, suggesting that levels below 6 micro units per milliliter indicate insulin sensitivity, while levels in the high teens to 20s may indicate a problem. They also criticize the broad 'normal' range provided by major diagnostic labs, which they believe reflects a misunderstanding of insulin resistance.

10:00

🩸 The Complexities of Hemoglobin A1C Testing

The speaker discusses the Hemoglobin A1C (HbA1C) test, which measures the degree of glycation of hemoglobin in red blood cells, and its limitations. They explain that glycation is a chemical process that can affect various parts of the body, not just hemoglobin. The speaker points out that factors affecting red blood cell lifespan can lead to falsely high or low A1C readings, independent of actual glucose levels. They also lament the decline of the oral glucose tolerance test, which they believe provides more detailed information about an individual's metabolic health.

15:02

πŸ– The Impact of Diet on Red Blood Cell Lifespan and A1C Levels

The speaker explores the impact of diet, specifically a carnivore diet, on red blood cell lifespan and A1C levels. They hypothesize that a diet focused on animal-sourced foods may lead to longer-lived red blood cells, potentially skewing A1C readings. They also discuss the role of iron, vitamin B12, and omega-3 fats in red blood cell health and how deficiencies can affect A1C levels. The speaker recommends the fructosamine test as a more accurate reflection of glycation for individuals following a carnivore diet.

20:04

🚫 The Overlooked Dangers of Fructose Glycation

The speaker raises concerns about the lack of clinical tests for fructose glycation, a process more reactive than glucose glycation and potentially more harmful. They discuss the ubiquity of fructose in modern diets and the potential for this to lead to widespread but undetected glycation damage. The speaker emphasizes the need for greater awareness among healthcare providers about the risks of fructose and the limitations of current testing methods.

25:05

πŸ“ˆ Uric Acid as a Surrogate Marker for Fructose Metabolism

The speaker discusses uric acid as a potential surrogate marker for fructose-induced glycation, given the absence of direct tests for fructosamine or fructose glycation. They explain the link between fructose metabolism and uric acid production and how this can impact inflammation and insulin resistance. The speaker also delves into the paradoxical effects of uric acid and ketones on inflammation, suggesting that ketones may counteract the pro-inflammatory effects of uric acid, leading to improved metabolic health despite elevated uric acid levels.

Mindmap

Keywords

πŸ’‘Insulin

Insulin is a hormone produced by the pancreas that regulates blood sugar levels by allowing glucose to enter cells to be used for energy. In the video, the distinction is made between exogenous insulin, which is insulin administered as a treatment for diabetes, and endogenous insulin, which is naturally produced by the body. The speaker emphasizes the importance of understanding endogenous insulin and its role in type 2 diabetes, challenging the common misconception that beta cells 'burn out' in type 2 diabetes.

πŸ’‘Beta Cells

Beta cells are a type of cell found in the islets of Langerhans in the pancreas, responsible for producing and secreting insulin. The script discusses the common misunderstanding that in type 2 diabetes, beta cells fail and stop producing insulin, which the speaker argues is not the case, and that beta cells are not 'gone' even in advanced stages of the disease.

πŸ’‘Type 2 Diabetes

Type 2 diabetes is a chronic condition that affects the way the body processes blood sugar (glucose). The video script focuses on the misconceptions surrounding the progression of type 2 diabetes, particularly regarding insulin production and the role of beta cells. The speaker asserts that type 2 diabetes is often mismanaged by focusing on glucose levels rather than insulin resistance.

πŸ’‘Insulin Resistance

Insulin resistance is a condition in which the body's cells do not respond properly to the hormone insulin, leading to high blood sugar levels. The script explains that insulin resistance is a critical factor in type 2 diabetes, and that the conventional focus on glucose levels can obscure the importance of addressing insulin resistance.

πŸ’‘Fasting Insulin Levels

Fasting insulin levels refer to the amount of insulin in the blood after an overnight fast. The speaker in the video advocates for the measurement of fasting insulin levels as a key clinical marker for assessing insulin resistance and metabolic health, arguing that current standards for what is considered 'normal' may be too high.

πŸ’‘Hemoglobin A1c (A1C)

Hemoglobin A1c, or A1C, is a blood test that measures the average blood sugar levels over the past 2 to 3 months. It reflects the degree of glycation, or binding of glucose to hemoglobin. The script discusses the limitations of A1C as a diagnostic tool, as it can be falsely elevated or decreased due to factors that affect red blood cell lifespan.

πŸ’‘Glycation

Glycation is a chemical reaction between sugar molecules and proteins, lipids, or other sugars, resulting in the formation of new compounds known as advanced glycation end products (AGEs). The video explains that glycation is not limited to hemoglobin but can occur throughout the body, affecting various tissues and contributing to conditions like atherosclerosis and premature aging.

πŸ’‘Oral Glucose Tolerance Test

The oral glucose tolerance test (OGTT) is a diagnostic test for diabetes that involves measuring blood sugar levels before and at intervals after consuming a glucose-rich beverage. The speaker in the video laments the decline in use of the OGTT, suggesting it provides more detailed information about glucose metabolism than the A1C test.

πŸ’‘Fructosamine

Fructosamine is a blood test that measures the amount of glucose that has bound to proteins in the blood, reflecting short-term blood sugar control. The script mentions fructosamine as an alternative test to A1C for assessing glycation, especially in cases where red blood cell lifespan might skew A1C results.

πŸ’‘Uric Acid

Uric acid is a waste product that results from the breakdown of purines, and its levels in the blood can be an indicator of various metabolic conditions. The video discusses uric acid as a surrogate marker for fructose metabolism and its potential role in insulin resistance and inflammation, particularly in the context of ketogenic diets.

πŸ’‘Ketones

Ketones are molecules that the body produces as a byproduct of fat metabolism when glucose is not available. The script highlights the anti-inflammatory properties of ketones, suggesting they may counteract the pro-inflammatory effects of uric acid, which is particularly relevant for individuals following ketogenic diets.

Highlights

Insulin understanding has shifted from exogenous to a focus on endogenous insulin and its importance in type 2 diabetes.

Mainstream medicine often overlooks the role of endogenous insulin produced by the pancreas in type 2 diabetes management.

A common misconception is that beta cells burn out in type 2 diabetes, but in reality, they do not completely disappear.

Insulin resistance and production levels vary among individuals, and insulin levels remain high even when production starts to decline.

The conventional focus on glucose levels neglects the importance of insulin as a sensitive and early marker in diabetes.

Increasing insulin dosage in type 2 diabetics does not improve outcomes and can increase mortality.

The importance of measuring fasting insulin levels early in a patient's metabolic health assessment.

Fasting insulin levels can indicate insulin sensitivity, with levels below 6 Β΅U/mL being very good.

High fasting insulin levels (high teens to 20s) can signal compromised metabolic health.

The need for clinicians to measure insulin levels as a clinical marker for better diabetes management.

LabCorp and Quest consider fasting insulin levels below 25 Β΅U/mL as normal, which may not be accurate.

A1C test has limitations and can be falsely elevated or decreased due to factors affecting red blood cell lifespan.

The oral glucose tolerance test provides more detailed information than A1C but is less commonly used.

Glycation is a broader process affecting all cells in the body, not just hemoglobin in red blood cells.

Uric acid levels can serve as a proxy for fructose-induced glycation, which is not directly measurable.

Ketones have anti-inflammatory properties that can counteract the inflammation caused by uric acid.

The paradox of elevated uric acid levels alongside improved metabolic and inflammatory markers on a ketogenic diet.

Transcripts

play00:00

e

play00:33

I want to start talking first with you

play00:35

about

play00:36

insulin uh in the first few years of my

play00:39

medical practice I definitely knew what

play00:41

insulin was 99% of my understanding was

play00:45

exogenous insulin and how to give that

play00:48

to people with diabetes uh but

play00:51

increasingly over the past few years all

play00:55

I care about all I want to focus on and

play00:57

study about is endogenous insulin the

play01:00

that's produced by the beta cells in the

play01:02

human pancreas and how important that is

play01:06

and how under underestimated and and not

play01:09

even underestimated by the mainstream uh

play01:13

primary care practitioner but just com

play01:15

they're completely oblivious to the

play01:19

insulin that's produced by the pancreas

play01:21

indeed I think if you lined up 100

play01:24

practicing Primary Care Providers and

play01:26

you ask them what happens to U the beta

play01:30

cells in a person with type 2 diabetes I

play01:33

think that the at least 70% of them

play01:36

would say well as your type two diabetes

play01:39

gets worse the the beta cells burn out

play01:43

and they stop producing insulin and

play01:45

that's why most people with type two

play01:47

diabetes when the disease gets bad

play01:48

enough they have to go on uh insulin

play01:51

injections walk us through how this

play01:54

is not true the vast majority of the

play01:57

time yeah yeah in fact I would even be

play02:00

more bold and bold enough indeed to say

play02:03

that if it is if it is actually type two

play02:05

diabetes and that's an important

play02:07

distinction because there is the kind of

play02:10

rare coincidence where someone with type

play02:12

two actually develops true type one but

play02:15

it's not a consequence of the type two

play02:18

diabetes that is just a bizarre

play02:20

Confluence of events that wherein this

play02:23

person has had this later in life

play02:25

autoimmune disease namely type one so my

play02:28

bold statement is in type two diabetes

play02:31

there will never be a situation in which

play02:34

the beta cells are gone it is true that

play02:38

in some instances insulin production has

play02:41

been going up for years in this

play02:43

individual and and then eventually the

play02:46

body becomes so resistant to its own

play02:47

insulin that the glucose starts to come

play02:50

up and then in some people so that's a

play02:52

reflection of the insulin resistance but

play02:54

in some individuals the insulin

play02:56

production will start to go down not all

play02:59

some just have have a straight line and

play03:00

the insulin is as high as ever sometimes

play03:03

the insulin will come down a little

play03:04

which further amplifies the glucose but

play03:07

even when the insulin starts to come

play03:08

down it is still much higher than it was

play03:11

before they ever started on this descent

play03:14

into metabolic derangement uh it's still

play03:17

multiples higher than it was before but

play03:20

all of this is just a reflection of how

play03:22

the conventionally trained clinician has

play03:24

been taught to focus on the glucose at

play03:28

the expense of the much more sensitive

play03:30

much earlier marker namely the insulin

play03:33

if we had trained these clinicians to

play03:35

have an insulin Centric view of type 2

play03:37

diabetes in particular then we wouldn't

play03:40

say let's lower that glucose at all

play03:43

costs even if we have to push the

play03:45

insulin up even higher which is a very

play03:46

common course of treatment and yet it

play03:48

doesn't work to help improve any outcome

play03:51

the more you give the type two diabetic

play03:53

more insulin the more they die

play03:55

absolutely and do you believe that every

play04:00

clinician should be trained by some

play04:04

Society or organization to check fasting

play04:07

insulin levels very very early in their

play04:10

patients metabolic career so to speak

play04:13

and if so what do you what would you

play04:16

consider an insulin level that's too

play04:19

high yeah in fact indeed Ken that is the

play04:23

drum I beat louder than any other if I

play04:25

can end my career um with having

play04:28

realized one single outcome namely that

play04:30

insulin becomes a more commonly measured

play04:33

clinical marker than I will have

play04:34

considered my career a success frankly

play04:38

um so that is absolutely the drum I beat

play04:40

the loudest and it's difficult to get a

play04:42

firm cut off now I'm going to give them

play04:44

anyway but I want people to know that

play04:46

insulin like almost every hormone in the

play04:48

body does have a little bit of Rhythm to

play04:50

it and it has a little play and and so

play04:53

while I'm going to give some hard cut

play04:54

offs please everyone know that it's

play04:57

possible to kind of be outside of this

play05:00

and it be a bit of a false indicator now

play05:02

having said that if someone has a fasted

play05:04

insulin that is six micro units per Mill

play05:06

or less that's a very very good sign

play05:09

that they're insulin sensitive if

play05:11

someone has uh fasting insulin that goes

play05:13

from seven to about the mid teens let's

play05:15

say seven to 17 just to kind of create a

play05:18

nice range there that's a possible

play05:20

problem now I emphasize possible because

play05:23

it's it is possible that someone comes

play05:25

in and gets a fasted insulin measurement

play05:27

and it's at 11 but that just happened to

play05:30

be the high point in their natural

play05:32

little rhythm and in fact in most of the

play05:34

time they're down around three or four

play05:36

so that's why I say that's a bit of a

play05:38

warning range but then if it's High

play05:41

Teens into the 20s that's generally

play05:42

going outside the natural oscillation of

play05:46

insulin and then the score starts to get

play05:48

a little compromised now please pardon

play05:50

the Shameless plug in my newest book how

play05:53

not to get sick that's this book right

play05:55

here I actually give a bunch of clinical

play05:57

tests and have people create a bit of a

play06:00

an Al an amalgamation of all of these

play06:03

numbers to really come to a firm

play06:06

understanding of their own insulin

play06:07

resistance but fasting insulin is the

play06:09

first one I talk about because it is the

play06:11

one that I think is the most overlooked

play06:13

for the value that it provides oh I

play06:16

totally agree and you know lab core and

play06:18

Quest the two largest diagnostic labs in

play06:22

the United States uh both have a any any

play06:25

fasting insulin that's less than 25 they

play06:28

consider that normal

play06:30

isn't that remarkable and and to me

play06:32

that's severe hyperinsulinemia if you're

play06:35

that's just further evidence that the

play06:37

average American because those those

play06:39

blood those blood um C offs those ranges

play06:41

are provided based on kind of national

play06:44

averages yes that to me is just further

play06:47

evidence of the problem that the average

play06:49

American is so insulin resistant that we

play06:51

think anything up to the mid-20s is

play06:54

normal that's not normal I totally agree

play06:57

let's let's talk about A1 C uh this is a

play07:01

and again this if I ask that same 100

play07:04

Physicians you've got a 40y old patient

play07:06

who's slightly overweight their blood

play07:07

pressure is a little high uh but their

play07:10

fasting blood glucose is normal or just

play07:13

a tiny bit elevated should you check an

play07:15

A1C on that patient I think that at

play07:17

least 40 if not 50% of those Primary

play07:20

Care Providers would say no I don't

play07:22

think it's worth the money uh let's talk

play07:25

about the A1C test what it checks what

play07:27

can falsely Elevate or falsely decrease

play07:30

it and is there another test that we

play07:32

should be considering if your A1C seems

play07:35

to be falsely High yeah in fact let me

play07:37

start with that last point because there

play07:39

there are a group of there have been

play07:41

several biomedic scientists that have

play07:43

bemoaned the shift in clinical practice

play07:46

um to focus on A1C given its its

play07:50

challenges which which I'll elaborate on

play07:53

in a moment but but boning it

play07:55

particularly because with the rise of

play07:57

A1C came the death of the oral glucose

play08:00

tolerance test that used to be a more

play08:02

commonly used clinical intervention but

play08:05

you know it's a little timec consuming

play08:07

which means it's more financially it's

play08:08

more costly um there's a little more

play08:11

Nuance into its interpretation but it

play08:13

gives far more detail than the A1C gives

play08:16

for reasons that I'll get into in just a

play08:18

second but by way of brief background

play08:21

it's helpful for people just to

play08:23

appreciate that glycation is this

play08:25

chemical process that is uh a function

play08:29

of a reducing sugar irreversibly non

play08:32

non-enzymatically so it doesn't need an

play08:34

enzyme to do it it doesn't need

play08:35

something to kind of mediate the two and

play08:37

bring them together it's just this

play08:39

reducing sugar glucose fructose

play08:42

galactose even other molecules that you

play08:45

wouldn't think of um can fit into this

play08:48

where they will irreversibly bind to a

play08:50

protein or DNA um or a lipid and create

play08:55

this glycation end product now

play08:57

importantly and this in fact is somewhat

play08:59

driven from a conversation that Ken and

play09:01

I have had just recently that term

play09:04

glycation can even be invoked with other

play09:07

reducing sugar so it's important for

play09:09

people to know that that term is

play09:11

sometimes used as an all-encompassing

play09:13

term even though as we'll get into not

play09:16

all tests will measure all of that but

play09:19

it's important for people to realize

play09:21

that as much as we focus on hba1c or

play09:24

hemoglobin

play09:25

A1c this is in fact itself a reflection

play09:29

of

play09:30

of glycation that can be happening

play09:32

everywhere it's just not easy to measure

play09:34

glycation in the kidney which is going

play09:37

to be increasing the risk of kidney

play09:39

failure or it's not easy to measure the

play09:41

degree of glycation in the blood vessels

play09:44

which is a very telling feature for

play09:46

atherosclerosis or the the synthesis or

play09:48

the beginning of an atherosclerotic

play09:50

plaque so as much as we just want to

play09:52

look at hba1c as some marker of glucose

play09:55

in the blood we should also appreciate

play09:57

that it can potentially be a sign of

play10:00

glycation that's happening everywhere

play10:02

even skin collagen causing wrinkles and

play10:05

premature aging of the skin all of these

play10:08

things can be impacted by glycation so

play10:10

it helps us appreciate hba1c which if we

play10:14

just drill right down to it is US

play10:16

measuring the degree to which we've had

play10:19

this irreversible glycation binding to

play10:22

the functional part of the red blood

play10:24

cell and very briefly within the red

play10:27

blood cell we have this comp complicated

play10:29

protein structure called hemoglobin

play10:32

hemoglobin's most famous job is to carry

play10:35

oxygen and at the same time to carry

play10:38

some other gases even like carbon

play10:39

dioxide albeit to lesser degrees one

play10:42

immediate effect at the red blood cell

play10:45

is that the more it is glycated the less

play10:48

suitable it is now to carry oxygen so

play10:51

one immediate consequence of this is the

play10:53

person's reduced ability to move oxygen

play10:56

potentially creating conditions of

play10:58

hypoxia or compromised oxygen movement

play11:02

through the body now this of course

play11:04

becomes a particular problem in a

play11:06

diabetic and someone who's chronically

play11:08

hypoglycemic they not only have the the

play11:11

the glycation of the blood vessels

play11:13

damaging blood vessels but to compound

play11:16

that they also have the blood itself not

play11:18

carrying oxygen as well so no wonder

play11:21

they develop such poor wounds and and

play11:24

sort of Decay flesh because the blood

play11:27

isn't flowing very well so it's

play11:29

important for people to appreciate that

play11:31

what glycation is and how the hb1c is a

play11:35

reflection of a greater wholebody

play11:38

phenomenon but then kenu

play11:40

mentioned where it can be sort of

play11:43

misdiagnosed or misunderstood it is so

play11:46

important for people to realize the the

play11:49

the problem with hba1c namely that while

play11:51

we always focus on hba1c as a

play11:55

consequence of hyperglycemia we need to

play11:58

remember that there's another part of of

play11:59

this formula that when we're measuring

play12:02

hba1c as much as we say it's a marker of

play12:05

gly of glucose and glycation we could

play12:07

also say someone could equally make the

play12:10

argument that no it's actually uh a

play12:12

result of how long lived the red blood

play12:14

cells are because a red blood cell that

play12:17

lives longer that has gone beyond its

play12:21

120 average days of life it just becomes

play12:24

more likely that it will experience some

play12:27

degree of glycation that's not the red

play12:29

blood cell's fault it's not even

play12:31

glucose's fault it's just the longer it

play12:33

has lived the more likely it is to have

play12:35

undergone some degree of glycation thus

play12:37

you could have someone who has very

play12:39

long-lived red blood cells has very

play12:42

normal glucose and yet the their A1C is

play12:45

high it's a false positive it's a false

play12:48

sign of glucose and that's more a

play12:50

function of the red blood cell living

play12:51

long in contrast you could have someone

play12:54

who has very short-lived red blood cells

play12:56

perhaps because they're iron deficient

play12:58

or they vit Vin B12 deficient alol yeah

play13:02

yeah right yes so they a disease where

play13:04

the red blood cells have a very short

play13:06

life they turn over much more rapidly in

play13:09

this case the red blood cells are never

play13:11

around long enough to even undergo

play13:13

glycation even if a person's fasting

play13:16

glucose levels are high and they're

play13:19

struggling with hypoglycemia so in this

play13:21

case it's a false negative where the A1C

play13:24

looks normal but in fact there is a

play13:27

glucose problem it's just that the

play13:29

fragility of that person's red blood

play13:31

cells mask it you don't see it so people

play13:35

we have to appreciate that while AWC has

play13:37

value while it can be a sign of

play13:39

glycation occurring elsewhere in the

play13:41

body it also can't be taken as the

play13:44

gospel Truth where it is the endall

play13:47

marker of metabolic Health like you

play13:49

started the conversation with we have

play13:51

become so obsessed with A1C that we

play13:54

refuse to acknowledge its flaws yeah and

play13:58

any good doctors should know the list of

play14:01

things that can shorten the life of a

play14:03

red blood cell and give you a falsely

play14:05

low A1C they should also know the list

play14:07

of things that can cause your red blood

play14:09

cells to live longer and thus give you a

play14:13

falsely high A1C but I I can just tell

play14:15

you from personal experience the vast

play14:17

majority of Primary Health Care

play14:19

Providers they might know about

play14:21

alcoholism but that's that's literally

play14:24

the extent of their knowledge about what

play14:26

could give a falsely high or low A1c

play14:30

uh so I have noticed a signal and that's

play14:33

as a primary care doctor I look for

play14:34

signal in patients right I i' change

play14:37

something and then when they come back

play14:38

in three or six months I'm like okay has

play14:41

that made a noticeable difference in

play14:43

enough people routinely enough

play14:47

predictably enough that I can say okay I

play14:48

need to adjust my practice based on that

play14:51

uh I have seen a signal in the carnivore

play14:54

Community very meat heavy meat Centric

play14:57

diets where I'd say 5% five out of a 100

play15:01

carnivores will notice that their a1c's

play15:04

creeping back up not never to di to

play15:08

diabetic levels but maybe 5.7 5.8

play15:12

5.9 and many of we you and I have

play15:15

discussed this before and I've discussed

play15:17

this with Shawn Baker and many other

play15:18

people in the carnivore Community How

play15:21

likely is that that now that they're not

play15:23

eating all the inflammatory hypoglycemic

play15:27

Foods How likely is it that the red

play15:29

blood cells are just living longer now

play15:32

than 110 days which seems to be the

play15:34

average it's living 120 130 140 days How

play15:38

likely is that and how can we ever dig

play15:41

into that and and maybe provide some

play15:43

proof and some reassurance to the

play15:45

carnivore Community oh yeah in fact my

play15:48

whole um viewpoint on it that I just

play15:51

elaborated with regards to the failure

play15:53

to appreciate variables that influence

play15:55

the longevity or the lifespan of a red

play15:57

blood cell actually was born from this

play16:00

very issue where I would hear from

play16:03

carnivores where they would say hey I

play16:06

don't know what's going on I reversed my

play16:07

type two diabetes but yet my A1C is

play16:10

creeping um it's exactly what you just

play16:12

said and it was me wondering how could

play16:15

the physiology fit into this that led me

play16:17

to these conclusions all of which is

play16:19

supported so just to kind of revisit

play16:21

that I had mentioned two variables

play16:23

namely iron which is a fundamental

play16:25

component of hemoglobin in order to

play16:27

carry the oxygen this is why someone

play16:30

who's iron deficient will experience the

play16:32

most common type of anemia on the planet

play16:34

which is iron deficiency anemia the

play16:36

number of red blood cells is fine but

play16:39

the ability of the red blood cells to

play16:41

carry oxygen is not because in the

play16:43

absence of heem iron consumption you're

play16:45

not going to have sufficient iron uh

play16:47

oxygen binding capacity and then I'd

play16:50

mentioned vitamin B12 once again this is

play16:54

becomes relevant the further someone

play16:56

gets from eating animal sourced Foods

play16:58

because there is no plant version

play17:01

there's no plant source of vitamin B12

play17:04

and in this case it gives rise to

play17:06

another one of the most common types of

play17:07

anemia worldwide which is pernicious

play17:09

anemia that's a fascinating physiology

play17:12

to it or cell biology and I won't bore

play17:15

everyone with the details that I share

play17:17

when I teach this principle to my

play17:18

students but basically in this scenario

play17:23

the the bone marrow which is the origin

play17:24

of the red blood cell it has enough

play17:27

material to to prepare the the precursor

play17:31

cells the cells that are going to

play17:33

someday become red blood cells normally

play17:35

the process is the cells will grow and

play17:37

then divide grow and then then divide in

play17:40

the absence of sufficient B12 because

play17:43

for example the person isn't consuming

play17:45

animal products or because they've had

play17:47

gastric bypass and they don't have

play17:49

enough of a stomach left to to absorb

play17:52

the B12 so they need injections forever

play17:54

but in that case the bone marrow is able

play17:56

to grow the progenitor red blood cell

play17:59

but not actually divide them so the

play18:01

person has this kind of paradoxical

play18:03

situation where the cells are big but

play18:05

they're just not nearly enough and so in

play18:08

this case once again the person has they

play18:11

have the risk of having so few red blood

play18:13

cells that it can give you know a sort

play18:15

of mistaken um number here with A1C then

play18:18

my last point would be the fluidity um

play18:22

the ability of the red blood cell to be

play18:24

as dynamic as it needs to be the red

play18:26

blood cell is very unique among all

play18:28

cells in the body in that while it

play18:31

doesn't it has very little by way of

play18:33

internal structure that enables it to

play18:36

slip through incredibly tight spaces to

play18:39

move in and out of sinuses and

play18:41

capillaries and to do that it needs to

play18:43

be very pliable and Squishy well the

play18:46

more omega-3 fats you're eating the more

play18:48

those fats get enriched in the membrane

play18:52

of the cell allowing it to have a higher

play18:54

fluidity to give it a little bit of

play18:56

Squish and mean making it so that it can

play18:59

fit through spaces without shattering as

play19:02

opposed to other fats that start to get

play19:04

enriched in that membrane which can make

play19:06

it a little more rigid so for these

play19:09

three reasons in addition to several

play19:11

others the more a person is changing the

play19:15

diet to be to quote you a proper human

play19:17

diet focused on animal sourc Foods the

play19:20

more those red blood cells are likely to

play19:22

be more robust a little heer longer

play19:26

lived and thus increasing the potential

play19:29

of the individual having an artificially

play19:32

inflated

play19:33

A1C and in people like that in the five%

play19:36

of carnivores that I'm seeing I don't

play19:38

know if you're seeing a different

play19:40

percentage but if they have an A1C

play19:42

that's a little bit elevated and they're

play19:44

like what's going on here the test I

play19:46

recommend is a

play19:47

fructosamine test I used to recommend a

play19:50

glycated albumin but labor and Quest

play19:53

both stop offering that test but the

play19:57

fructosamine even though fructo is in

play19:59

the name it checks only for glucose

play20:04

glycation uh it looks for the the

play20:06

glucose lysine Bond I think is what it

play20:09

actually looks for and invariably every

play20:12

time a carnivore gets a fructosamine

play20:15

checked it's within normal limits uh

play20:17

verifying verifying that they are not

play20:20

overly glycating it's just that the red

play20:22

blood cells almost certainly are living

play20:24

longer because of their healthier diet

play20:27

and I I want to dig into that a little

play20:29

bit to my

play20:31

knowledge there is no commercially

play20:33

available test that a doctor can order

play20:37

that checks for fructation or fructose

play20:40

glycation and This concerns me because

play20:43

there are many doctors out there who are

play20:45

recommending to their patients eat lots

play20:47

of fruits and vegetables and you know

play20:50

what the patient's going to focus on the

play20:52

one that taste better and the one that

play20:53

they don't hate which is fruit and so

play20:56

they wind up living on fruit juice

play20:57

smoothies but but when you check an

play21:00

A1C you don't you don't see reflected

play21:03

you don't that fructose glycation and I

play21:07

I want I want to reiterate a point you

play21:08

said earlier which is super important

play21:10

because a lot of people if you're not a

play21:11

doctor or a PhD you just think oh well

play21:15

glucose just glyc hates hemoglobin right

play21:18

in the red blood cell that's that's what

play21:20

it does that's the bad thing that it

play21:22

does but Professor bman was very clear

play21:25

it glyc hates every cell in your body

play21:30

the cells in the nefron of the kidney

play21:32

the cells in your heart your cardio

play21:35

myocytes literally every cell in your

play21:37

body is also being glycated we just use

play21:41

the glycation of the hemoglobin molecule

play21:43

the A1C as a proxy marker for all this

play21:47

other dangerous glycation that's going

play21:49

on in the human body do you know of a

play21:52

test that a doctor can order because I

play21:54

don't know of one that checks for

play21:57

fructose gly or even when it comes to

play22:00

drinking milk galactose gation because I

play22:03

do not know of a test no no I don't

play22:06

either um in fact I love in fact this

play22:08

was something that as you and I have

play22:10

communicated this you you opened my eyes

play22:13

to this um so so we know that fructose

play22:16

is much more reactive than glucose which

play22:20

makes this part of the conversation all

play22:21

the more relevant as much as we focus on

play22:24

glucose and and rightly so fructose is

play22:27

known to elicit the these reactive

play22:29

reactions that's a little redundant

play22:31

these glycation reactions again that

play22:33

being a broad term to refer to any

play22:35

reducing sugar binding irreversibly

play22:38

these molecules it seven times more than

play22:40

glucose so to make sayate that again

play22:42

because it was a bit awkwardly delivered

play22:44

fructose can induce glycation seven

play22:46

times more readily than glucose can and

play22:49

and thus I think it is uh much more

play22:52

relevant but no no all the more tragic

play22:55

this fact is made this is a this is a

play22:58

non

play22:59

enzymatic glycation this is does not

play23:01

require an enzyme this is not a pathway

play23:04

this is just a function of basically how

play23:06

much fructose is in your bloodstream the

play23:09

the higher the level the more the

play23:11

glycation is going to be is that correct

play23:13

there's no there's no clinical test to

play23:15

answer the question no unfortunately

play23:16

there's no way to do it so basically

play23:19

people who are living on fruit juice

play23:20

smoothies are eating hundreds of grams

play23:22

of carbohydrates in fruit or fruit juice

play23:25

per day there's currently all Healthcare

play23:28

providers are blind to the fructose

play23:30

glycation you cannot detect it yeah

play23:33

that's right in fact I would say can at

play23:35

the risk just to give some answer if

play23:37

perhaps the closest a person could come

play23:39

to understanding their fructation or the

play23:42

degree of fructose induced glycation it

play23:44

would probably be uric acid just as a

play23:46

surrogate marker because uric acid just

play23:48

runs so tightly with fructose metabolism

play23:52

which itself of course is a product of

play23:54

fructose consumption so yeah probably

play23:57

the closest we can get is getting a uric

play23:59

acid marker I I agree with you I think

play24:01

uric acid is a a fairly good rough proxy

play24:04

marker for the degree of fructation uh

play24:08

what else do people need to know about

play24:09

uric acid levels and how they how they

play24:14

give us insight into our own metabolism

play24:17

yeah yeah in fact what a timely question

play24:21

because what if if what I was doing

play24:23

literally one hour ago was working on a

play24:25

manuscript that we are preparing to

play24:27

publish this is something I've alluded

play24:29

to over the past year or so it's finally

play24:32

come to fruition and we're going to

play24:33

submit it for publication the joys of

play24:36

being a publishing scientist is the

play24:38

frustration of trying to then get your

play24:39

work published but I do it for the

play24:42

students because these are all

play24:43

student-led projects and I want them to

play24:45

have that experience and then have that

play24:47

help them get onto their next part of

play24:49

their lives and career so what we found

play24:52

was so so briefly uric acid um and and

play24:56

my friend and even collabor on this

play24:58

project Dr Rick Johnson has really been

play25:01

the champion I was unaware I'll confess

play25:04

of the effects of of FR of uric acid let

play25:07

alone the involvement of fructose until

play25:09

I read his work and became familiar with

play25:11

him and it's been one of the great joys

play25:13

of my life professionally to get to know

play25:15

him better and now consider him a friend

play25:17

he's a wonderful gentleman scientist

play25:19

great guy he was really the one who

play25:22

highlighted that every time your cell is

play25:24

metabolizing a molecule of fructose it's

play25:26

giving birth to a molecule of uric acid

play25:29

which makes it far more relevant to uric

play25:32

acid production than any amount of meat

play25:34

or fish consumption which is an idea

play25:36

that just continues to really fail you

play25:39

see in the highest meat consuming

play25:41

populations on the planet like Hong Kong

play25:43

and Argentina their their uric acid

play25:45

levels are are nothing they're

play25:47

absolutely bottomed out and so let's we

play25:50

just have to kind of drop this idea that

play25:52

it's Meat and Fish that's contributing

play25:54

to uric acid no it's fructose look at

play25:56

those societies that are eating a lot of

play25:58

fructose or a lot of sugar or drinking a

play26:00

lot of fruit juice then you'll see the

play26:02

uric acid then uric acid itself can have

play26:05

Myriad consequences including what Rick

play26:08

has outlined namely stimulating hunger

play26:11

what I have focused on and back to the

play26:13

paper we're publishing is looking at how

play26:16

uric acid is a contributor to insulin

play26:19

resistance however I consider a

play26:22

secondary cause because it happens

play26:24

through its increase in inflammation

play26:26

uric acid is known to be an activator of

play26:29

inflammation now what we're studying is

play26:32

to try to reconcile the the Paradox that

play26:36

some people notice on a ketogenic diet

play26:38

which is twofold on one hand they may

play26:41

notice that in some people the uric acid

play26:43

levels stay high or even go up a little

play26:46

second their inflammatory markers have

play26:48

absolutely dropped so they much less

play26:51

inflammation and indeed much greater

play26:53

improvements in insulin sensitivity as

play26:55

evidenced by their resolution of type

play26:57

two diabetes this shouldn't be happening

play27:00

given Uric acid's involvement however

play27:02

what we are publishing so this is early

play27:05

data here um so unpublished results at

play27:07

the moment is that ketones are are

play27:11

sufficient to wipe out the inflammation

play27:14

caused by uric acid so ketones are known

play27:16

to be anti-inflammatory molecules so

play27:19

this is another instance whereby ketones

play27:22

have gone beyond their simple caloric

play27:25

value ketones have a caloric value

play27:27

roughly compar able to glucose which is

play27:29

good news for all the cells that want to

play27:31

use the ketones as energy but at the

play27:33

same time ketones act as a signaling

play27:36

molecule and in this case controlling

play27:40

literally inhibiting inflammation so

play27:42

whereas uric acid levels are trying to

play27:44

stimulate this kind of metabolic

play27:46

inflammation ketones are inhibiting it

play27:49

and that might help us reconcile how we

play27:51

could have a situation where a person

play27:53

has stubbornly elevated uric acid and

play27:56

yet every metabolic and indeed

play27:58

inflammatory marker has improved it's

play28:01

because there's a lot else going on

play28:03

including the contribution of the

play28:04

ketones to directly antagonize the

play28:07

pro-inflammatory effects of the uric

play28:08

acid

Rate This
β˜…
β˜…
β˜…
β˜…
β˜…

5.0 / 5 (0 votes)

Related Tags
Insulin ManagementDiabetes CareEndogenous InsulinExogenous InsulinHealthcare ProvidersMetabolic HealthFasting InsulinA1C TestFructosamine TestKetogenic DietInflammation Control